Alex Abuin

Alex Abuin currently serves as the Director of R&D and Professor of the Practice at Eshelman Innovation, focusing on translating innovative therapeutic approaches into early-stage assets with strong preclinical data. Additionally, Alex is a Research Assistant Professor in the SPARK Program at the University of Vermont, where efforts are directed toward bridging biomedical research and market applications. Previous experience includes roles as Executive Director of Portfolio Management at Nurix, Inc., and Director of Strategic Industry Ventures at MD Anderson Cancer Center, emphasizing partnerships in drug development. Alex's foundational career includes positions at Lexicon Pharmaceuticals and SmithKline Beecham Pharmaceuticals, contributing to advancements in molecular genetics and drug discovery. Alex holds a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine and a B.S. in Biology from the University of North Carolina at Charlotte.